Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
about
Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factorsEpilepsy in glioblastoma patients: basic mechanisms and current problems in treatment.ABC transporters as differentiation markers in glioblastoma cells.Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.Immunohistochemical study of MRP5 expression in meningiomas.
P2860
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@en
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@nl
type
label
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@en
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@nl
prefLabel
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@en
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.
@nl
P2093
P2860
P1476
Prognostic significance of MRP5 immunohistochemical expression in glioblastoma
@en
P2093
Anastasia Zikou
Andreas D Fotopoulos
Anna Goussia
Antigoni Ntoulia
Athanasios P Kyritsis
George A Alexiou
Maria I Argyropoulou
Perikles Tsekeris
Spyridon Voulgaris
P2860
P2888
P304
P356
10.1007/S00280-012-1832-Z
P577
2012-01-26T00:00:00Z